Management of disease progression after autologous hematopoietic stem cell transplantation in systemic sclerosis: Results from an international questionnaire-based study

By sjmartinez • February 7, 2025

Spierings J, Bandini G, Allanore Y, Papa ND, Denton CP, Distler O, Furst DE, Greco R, Khanna D, Kuwana M, Matucci-Cerinic M, Nikpour M, van Rhenen A, van Laar JM, Hughes M. Management of disease progression after autologous hematopoietic stem cell transplantation in systemic sclerosis: Results from an international questionnaire-based study. Semin Arthritis Rheum. 2025 Jan 31;71:152638. doi: 10.1016/j.semarthrit.2025.152638. Epub ahead of print. PMID: 39914262.

Tags: Autologous hematopoietic stem cell transplantation, disease progression, maintenance therapy, Publications, Rheumatology, Scleroderma, stem cell therapy, systemic sclerosis

Related Posts

Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene

Srinagesh HK, Gupta VK, Zhang A, Grunwald MR, Connor MP, Kota VK, Boccucci J, Ulrickson ML, Pradeep R, Hill LC, Tsai SB, O'Connor TE, Sandhu[...]

Reperfusion Strategies for Acute Pulmonary Embolism: Design and Rationale of RECONNECT-PE – a Living Systematic Review and Meta-analysis

Farmakis IT, Binder H, Chopard R, Christodoulou KC, Evrenoglou T, Fengler K, Giri J, Hobohm L, Jaber WA, Klok FA, Kocka V, Kroupa J, Kucher[...]

Neoadjuvant Stereotactic Body vs. Conventionally Fractionated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Propensity Score-Matched Analysis

Shimizu T, Zheng S, Maeda S, Link J, Deranteriassian A, Premji A, King J, Girgis M, Hines OJ, Wainberg Z, Raldow A, He J, Burns[...]